A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
| Prif Awdur: | |
|---|---|
| Awduron Eraill: | |
| Fformat: | Traethawd Ymchwil |
| Iaith: | English |
| Cyhoeddwyd: |
Brac University
2024
|
| Pynciau: | |
| Mynediad Ar-lein: | http://hdl.handle.net/10361/24298 |